Please ensure Javascript is enabled for purposes of website accessibility

New paper from our US collaborators Viewpoint Molecular Targeting, Inc., who use BIOEMTECH gamma-eye to in vivo image [203Pb]Pb-PSC-PEG-T and [212Pb]Pb-PSC-PEG-T in mice.

In February 2, 2023
On 2023

Great images that show the accumulation on the tumors at 3h and 24h post administration, confirmed by biodistribution data at 24h. We are glad that our technology makes possible the in vivo imaging of the theragnostic pair 203Pb/212Pb, offering new tools to all groups who work in the emerging domain of theragnostic alpha emitter. Read the paper here: